ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

2018 ACR/ARHP Annual Meeting

October 19-24, 2018. Chicago, IL.

View by Number View by Title View Sessions
View by Date

Sunday, October 21, 2018

9:00AM-11:00AM
Abstract Number: 415
1-Year Outcomes from a Novel Physical Therapist-Administered Physical Activity Intervention after Total Knee Replacement: A Pilot Study
Orthopedics, Low Back Pain and Rehabilitation Poster – ACR/ARHP
9:00AM-11:00AM
Abstract Number: 145
1,25(OH)2D3 and Dexamethasone Additively Suppress Synovial Fibroblast Activation By CCR6+ T-Helper Memory Cells and Enhance the Effect of Tnfα Blockade
T Cell Biology and Targets in Autoimmune and Inflammatory Disease Poster
9:00AM-11:00AM
Abstract Number: 833
11 Patients with Relapsing Polychondritis Presenting with Severe Airways Disease in One Centre in UK
Vasculitis Poster I: Non-ANCA-Associated and Related Disorders
9:00AM-11:00AM
Abstract Number: 610
4 Years Follow-up of a Cohort of Patients with Rheumatoid Arthritis in Sustained Clinical Remission with Optimization of Biological Therapy
Rheumatoid Arthritis – Treatments Poster I: Strategy and Epidemiology
9:00AM-11:00AM
Abstract Number: 476
A Better Understanding of Childhood Sjögren Syndrome: Evaluation of the 2016 Acr/EULAR Classification Criteria for Use in Diagnosing Sjögren Syndrome in Children
Pediatric Rheumatology – Clinical Poster I: Lupus, Sjögren’s Disease, and Myositis
9:00AM-11:00AM
Abstract Number: 299
A Comparison of Persistent Versus Limited Frequent Emergency Department (ED) Utilization Among Systemic Lupus Erythematosus (SLE) Patients
Health Services Research Poster I – ACR/ARHP
9:00AM-11:00AM
Abstract Number: 325
A Comparison of RADAI5 and RAPID3 Disease Measures
Measures and Measurement of Healthcare Quality Poster I
9:00AM-11:00AM
Abstract Number: 215
A Decade Earlier- Onset of Symptoms of RA in the Indian (Asian) Cohort Compared to Dutch Cohort: Based on Meteor, a Global Database
Epidemiology and Public Health Poster I: Rheumatoid Arthritis
9:00AM-11:00AM
Abstract Number: 68
A Genome-Wide Association Study Identifies rs116199914 As an Intergenic Variant Associated with Carotid Intima-Media Thickness in Spanish Patients with Rheumatoid Arthritis
Rheumatoid Arthritis – Etiology and Pathogenesis Poster I
9:00AM-11:00AM
Abstract Number: 728
A Higher Activity Index at Initial Renal Biopsy Is Associated with Rapid Progression to Renal Failure in Patients with Refractory Lupus Nephritis
Systemic Lupus Erythematosus – Clinical Poster I: Clinical Manifestations and Comorbidity
9:00AM-11:00AM
Abstract Number: 61
A Human ACPA Monoclonal Antibody Is Preferably Localized at Inflammatory Gingival Tissue and Activates Osteoclastogenensis in Porphyromonas Gingivalis Infected SKG Mouse
Rheumatoid Arthritis – Animal Models Poster
9:00AM-11:00AM
Abstract Number: 177
A Needs Assessment to Inform Rheumatology Curriculum Re-Design for Internal Medicine Residents
Education Poster
9:00AM-11:00AM
Abstract Number: 380
A New Tool to Assess Muscle Strength in Polymyositis and Dermatomyositis: Hand-Held Dynamometry
Muscle Biology, Myositis and Myopathies Poster I: Clinical Features and Disease Course
9:00AM-11:00AM
Abstract Number: 676
A Novel Role for the Psoriatic Arthritis Impact of Disease Questionnaire
Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster I: Imaging, Clinical Studies, and Treatment
9:00AM-11:00AM
Abstract Number: 714
A Predictive Clinical-Immunological Index for Infections Unveils Novel Innate and Adaptive Immunity Abnormalities As Key Risk Factors for Infections in a Cohort of Patients with Systemic Lupus Erythematosus
Systemic Lupus Erythematosus – Clinical Poster I: Clinical Manifestations and Comorbidity
  • 1
  • 2
  • 3
  • …
  • 67
  • Next Page»
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology